| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.
Other companies in Aldeyra Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Aldeyra Therapeutics has a consensus price target of $7.25.
The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $0.89 last updated October 13, 2026 at 5:36 PM EDT.
There are no upcoming dividends for Aldeyra Therapeutics.
Aldeyra Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aldeyra Therapeutics.
Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
